Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis: Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

Bente Glintborg; Tina Marie Kringelbach; Estrid Vilma Solyom Høgdall; Inge Juul Sørensen; Dorte Vendelbo Jensen; Anne Gitte Loft; Oliver Hendricks; Inger Marie Jensen Hansen; Asta Linauskas; Salome Kristensen; Hanne Lindegaard; Henrik Nordin; Nils Bolstad; David Warren; Johanna Gehin; Guro Løvik Goll; Kathrine Lederballe Grøn; Grith Eng; Christian Enevold; Claus Henrik Nielsen; Julia Sidenius Johansen; Merete Lund Hetland

Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis: Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

Bente Glintborg, Tina Marie Kringelbach, Estrid Vilma Solyom Høgdall, Inge Juul Sørensen, Dorte Vendelbo Jensen, Anne Gitte Loft, Oliver Hendricks, Inger Marie Jensen Hansen, Asta Linauskas, Salome Kristensen, Hanne Lindegaard, Henrik Nordin, Nils Bolstad, David Warren, Johanna Gehin, Guro Løvik Goll, Kathrine Lederballe Grøn, Grith Eng, Christian Enevold, Claus Henrik NielsenJulia Sidenius Johansen, Merete Lund Hetland

Original language	English
Article number	1997
Journal	Arthritis & Rheumatology
Volume	68
Issue number	S10
Number of pages	4
ISSN	2326-5205
Publication status	Published - 2016

Access to Document

http://onlinelibrary.wiley.com/doi/10.1002/art.39977/full

Cite this

Glintborg, B., Kringelbach, T. M., Høgdall, E. V. S., Sørensen, I. J., Jensen, D. V., Loft, A. G., Hendricks, O., Hansen, I. M. J., Linauskas, A., Kristensen, S., Lindegaard, H., Nordin, H., Bolstad, N., Warren, D., Gehin, J., Goll, G. L., Grøn, K. L., Eng, G., Enevold, C., ... Hetland, M. L. (2016). Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis: Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry. Arthritis & Rheumatology, 68(S10), [1997]. http://onlinelibrary.wiley.com/doi/10.1002/art.39977/full

Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis : Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry. / Glintborg, Bente; Kringelbach, Tina Marie; Høgdall, Estrid Vilma Solyom et al.

In: Arthritis & Rheumatology, Vol. 68, No. S10, 1997, 2016.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Glintborg, B, Kringelbach, TM, Høgdall, EVS, Sørensen, IJ, Jensen, DV, Loft, AG, Hendricks, O, Hansen, IMJ, Linauskas, A, Kristensen, S, Lindegaard, H, Nordin, H, Bolstad, N, Warren, D, Gehin, J, Goll, GL, Grøn, KL, Eng, G, Enevold, C, Nielsen, CH , Johansen, JS & Hetland, ML 2016, 'Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis: Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry', Arthritis & Rheumatology, vol. 68, no. S10, 1997. <http://onlinelibrary.wiley.com/doi/10.1002/art.39977/full>

@article{01237a8d7c014b7ea43c0f76c987e38f,

title = "Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis: Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry",

author = "Bente Glintborg and Kringelbach, {Tina Marie} and H{\o}gdall, {Estrid Vilma Solyom} and S{\o}rensen, {Inge Juul} and Jensen, {Dorte Vendelbo} and Loft, {Anne Gitte} and Oliver Hendricks and Hansen, {Inger Marie Jensen} and Asta Linauskas and Salome Kristensen and Hanne Lindegaard and Henrik Nordin and Nils Bolstad and David Warren and Johanna Gehin and Goll, {Guro L{\o}vik} and Gr{\o}n, {Kathrine Lederballe} and Grith Eng and Christian Enevold and Nielsen, {Claus Henrik} and Johansen, {Julia Sidenius} and Hetland, {Merete Lund}",

year = "2016",

language = "English",

volume = "68",

journal = "Arthritis & Rheumatology",

issn = "2326-5205",

publisher = "Wiley",

number = "S10",

}

TY - ABST

T1 - Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis

T2 - Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry

AU - Glintborg, Bente

AU - Kringelbach, Tina Marie

AU - Høgdall, Estrid Vilma Solyom

AU - Sørensen, Inge Juul

AU - Jensen, Dorte Vendelbo

AU - Loft, Anne Gitte

AU - Hendricks, Oliver

AU - Hansen, Inger Marie Jensen

AU - Linauskas, Asta

AU - Kristensen, Salome

AU - Lindegaard, Hanne

AU - Nordin, Henrik

AU - Bolstad, Nils

AU - Warren, David

AU - Gehin, Johanna

AU - Goll, Guro Løvik

AU - Grøn, Kathrine Lederballe

AU - Eng, Grith

AU - Enevold, Christian

AU - Nielsen, Claus Henrik

AU - Johansen, Julia Sidenius

AU - Hetland, Merete Lund

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

SN - 2326-5205

VL - 68

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

IS - S10

M1 - 1997

ER -